Staphylococcus Enterotoxins and Clostridium Difficile Toxins

New C. Difficile and Staphylococcus toxin reagents to help advance your research
United States Biological is excited to introduce highly specific antibodies for Staphylococcus Enterotoxins and Clostridium difficile toxins to complement our extensive range of native toxins and toxoid proteins. Find out below how these new reagents can help to advance your research.

Staphylococcus Enterotoxin Antibodies

Enterotoxins A and B are major causes of food-borne infection, the clinical symptoms of which include fever, myalgia, vomiting, diarrhea, headaches, and in some cases toxic shock. Enterotoxins G and I have been associated with food poisoning outbreaks in Taiwan, and have also been linked to cases of toxic shock syndrome, Staphylococcal scarlet fever and neonatal enteropathy. Our new range of highly specific monoclonal antibodies recognise different members of the enterotoxin family, permitting a detailed analysis of their roles in pathogenicity.

Clostridium Difficle Toxins

C. difficile infection causes significant morbidity and mortality worldwide, and is recognized as a leading cause of severe gastrointestinal disease in hospitalised patients. Toxins A and B have been identified as major virulence factors – their proinflammatory and cytotoxic activity causing disruption to the intestinal epithelium, resulting in extensive damage and cell death. To support those working with C. difficile – either developing immunoassays or therapeutic strategies – we offer both native toxins and antibodies to recognise these toxins. Our highly purified C. difficile toxin preparations are suitable for a range of assays, including cytotoxicity, and are available in a range of pack sizes.

---